Authors:
Herrero, JI
Sangro, B
Quiroga, J
Pardo, F
Herraiz, M
Cienfuegos, JA
Prieto, J
Citation: Ji. Herrero et al., Influence of tumor characteristics on the outcome of liver transplantationamong patients with liver cirrhosis and hepatocellular carcinoma, LIVER TRANS, 7(7), 2001, pp. 631-636
Authors:
Blanco, JJ
Herrero, JI
Quiroga, J
Sangro, B
Gomez-Manero, N
Pardo, F
Cienfuegos, JA
Prieto, J
Citation: Jj. Blanco et al., Liver transplantation in cirrhotic patients with diabetes mellitus: Midterm results, survival, and adverse events, LIVER TRANS, 7(3), 2001, pp. 226-233
Authors:
Herrero, JI
Quiroga, J
Sangro, B
Beloqui, O
Pardo, F
Cienfuegos, JA
Prieto, J
Citation: Ji. Herrero et al., Hyperhomocysteinemia in liver transplant recipients: Prevalence and multivariate analysis of predisposing factors, LIVER TRANS, 6(5), 2000, pp. 614-618
Authors:
Bilbao, JI
Herrero, JI
Martinez-Cuesta, A
Quiroga, J
Pueyo, JC
Vivas, I
Delgado, C
Pardo, F
Citation: Ji. Bilbao et al., Ascites due to anastomotic stenosis after liver transplantation using the piggyback technique: Treatment with endovascular prosthesis, CARDIO IN R, 23(2), 2000, pp. 149-151
Authors:
Berasain, C
Betes, M
Panizo, A
Ruiz, J
Herrero, JI
Civeira, MP
Prieto, J
Citation: C. Berasain et al., Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology, GUT, 47(3), 2000, pp. 429-435
Authors:
Herrero, JI
Quiroga, J
Sangro, B
Girala, M
Gomez-Manero, N
Pardo, F
Alvarez-Cienfuegos, J
Prieto, J
Citation: Ji. Herrero et al., Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil, LIVER TR S, 5(5), 1999, pp. 414-420